Home Dezhan Healthcare Portfolio Company ApolloBio Announces Positive Topline Results for VGX-3100 China Phase III Pivotal Study

Dezhan Healthcare Portfolio Company ApolloBio Announces Positive Topline Results for VGX-3100 China Phase III Pivotal Study

May 20, 2026 18:59 CST Updated 19:22